Economic evaluation and access strategy development for the 20-valent pneumococcal conjugate vaccine (PCV20) in Spanish adults

Rejas Gutiérrez, JavierMartínez Martínez, Néstor2022-06-082022-06-082021-10-29https://hdl.handle.net/10016/35042Atribución-NoComercial-SinDerivadas 3.0 EspañaPneumococcal infectionPneumococcal pneumoniaCost-effectivenessPCV20Pneumococcal vaccines20-valent pneumococcal vaccineEconomic evaluation and access strategy development for the 20-valent pneumococcal conjugate vaccine (PCV20) in Spanish adultsmaster thesisEconomíaopen access